These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Histone deacetylase inhibitors in cancer therapy. Fouladi M Cancer Invest; 2006; 24(5):521-7. PubMed ID: 16939962 [No Abstract] [Full Text] [Related]
13. Pharmacokinetics, safety, and efficacy of a liposome encapsulated thymidylate synthase inhibitor, OSI-7904L [(S)-2-[5-[(1,2-dihydro-3-methyl-1-oxobenzo[f]quinazolin-9-yl)methyl]amino-1-oxo-2-isoindolynl]-glutaric acid] in mice. Desjardins J; Emerson DL; Colagiovanni DB; Abbott E; Brown EN; Drolet DW J Pharmacol Exp Ther; 2004 Jun; 309(3):894-902. PubMed ID: 14982966 [TBL] [Abstract][Full Text] [Related]
14. Determinants of the therapeutic efficacy of thymidylate synthase inhibitors. Peters GJ; Kuiper CM; van Triest B; Backus H; van der Wilt CL; van Laar JA; Jansen G; van Groeningen CJ; Pinedo HM Adv Exp Med Biol; 1998; 431():699-704. PubMed ID: 9598155 [No Abstract] [Full Text] [Related]
15. Inside the biochemical pathways of thymidylate synthase perturbed by anticancer drugs: Novel strategies to overcome cancer chemoresistance. Taddia L; D'Arca D; Ferrari S; Marraccini C; Severi L; Ponterini G; Assaraf YG; Marverti G; Costi MP Drug Resist Updat; 2015 Nov; 23():20-54. PubMed ID: 26690339 [TBL] [Abstract][Full Text] [Related]
16. Sequence-based identification of specific drug target regions in the thymidylate synthase enzyme family. Ferrari S; Losasso V; Costi MP ChemMedChem; 2008 Mar; 3(3):392-401. PubMed ID: 18270995 [No Abstract] [Full Text] [Related]
17. Aurora kinases dawn as cancer drug targets. Sausville EA Nat Med; 2004 Mar; 10(3):234-5. PubMed ID: 14991042 [No Abstract] [Full Text] [Related]
18. Issues and progress with protein kinase inhibitors for cancer treatment. Dancey J; Sausville EA Nat Rev Drug Discov; 2003 Apr; 2(4):296-313. PubMed ID: 12669029 [TBL] [Abstract][Full Text] [Related]
19. Phase I study of OSI-7904L, a novel liposomal thymidylate synthase inhibitor in patients with refractory solid tumors. Beutel G; Glen H; Schöffski P; Chick J; Gill S; Cassidy J; Twelves C Clin Cancer Res; 2005 Aug; 11(15):5487-95. PubMed ID: 16061865 [TBL] [Abstract][Full Text] [Related]
20. New targets for cancer chemotherapy. Murgo AJ; Dancey J; Eckhardt SG; Hidalgo M; Arbuck SG; Zerivitz K; Blaylock BA Cancer Chemother Biol Response Modif; 2002; 20():239-72. PubMed ID: 12703208 [No Abstract] [Full Text] [Related] [Next] [New Search]